Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

VKTX US Equity

Viking Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1607678 · FY ends Dec 31
$35.98
+2.61 (+7.82%)
USD · as of 2026-08-19 · marketstack
5 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-07-298-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-268-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-04-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-298-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-10-228-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-22

Every row is a filed document, checked against its EDGAR index.